EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies

Bárbara S Marques, Maria Mendes, José Luís Alves, Alberto Pais, Carla Vitorino

Molecular Diagnosis & Therapy · 2026-09 · 30 (5) · 739-757

DOI: 10.1007/s40291-026-00864-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Diagnosis & Therapy, online erschienen am 15.07.2026. Verfasst von Bárbara S Marques und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. Hauptthemen laut MEDLINE: Temozolomide, Drug Resistance, Neoplasm, CRISPR-Cas Systems, Antineoplastic Agents, Alkylating. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Universidade de Coimbra.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideDrug Resistance, NeoplasmCRISPR-Cas SystemsAntineoplastic Agents, AlkylatingGlioblastomaBrain NeoplasmsHumansAnimals

Substanzen

TemozolomideAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal.
  • Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal.
  • Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal. mmendes@ff.uc.pt.
  • Coimbra Chemistry Centre, Institute of Molecular Sciences - IMS, Department of Chemistry, University of Coimbra, Coimbra, Portugal. mmendes@ff.uc.pt.
  • Department of Neurosurgery, ULS Coimbra, Coimbra, Portugal.
  • Instituto Português de Oncologia, Coimbra, Portugal.

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Universidade de Coimbra

Zitieren

APA

Marques, B. S., Mendes, M., Alves, J. L., Pais, A., & Vitorino, C. (2026). Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies. Molecular Diagnosis & Therapy, 30(5), 739-757. https://doi.org/10.1007/s40291-026-00864-3

Vancouver

Marques BS, Mendes M, Alves JL, Pais A, Vitorino C. Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies. Molecular Diagnosis & Therapy. 2026;30(5):739-757. doi:10.1007/s40291-026-00864-3

BibTeX
@article{Marques2026,
  author = {Marques, Bárbara S and Mendes, Maria and Alves, José Luís and Pais, Alberto and Vitorino, Carla},
  title = {Decoding and Overcoming Temozolomide Resistance Through CRISPR/Cas Technologies},
  journal = {Molecular Diagnosis & Therapy},
  year = {2026},
  volume = {30},
  number = {5},
  pages = {739--757},
  doi = {10.1007/s40291-026-00864-3}
}
Kostenlos starten →